Related content

Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomy

By Kollermann J.   Caprano J.   Budde A.   Weidenfeld H.   Weidenfeld M.   Hopfenmuller W.   Helpap B.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 476-480

Elsevier

Access to resources Recommend Favorite

Prognosis of Stage pT0 after Prolonged Neoadjuvant Endocrine Therapy of Prostate Cancer: A Matched-Pair Analysis

By Kollermann J.   Hopfenmuller W.   Caprano J.   Budde A.   Weidenfeld H.   Weidenfeld M.   Helpap B.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 42-45

Elsevier

Access to resources Recommend Favorite

Long-term Follow-up of Breast-conserving Therapy in Patients with Inflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy

By Bonev Valentina   Evangelista Maristella   Chen Jeon-Hor   Su Min-Ying   Lane Karen   Mehta Rita   Butler John   Hsiang David  

The American Surgeon, Vol. 80, Iss. 10, 2014-10 ,pp. : 940-943

Southeastern Surgical Congress

Access to resources Recommend Favorite

Long-term follow-up after triple treatment of prostate cancer stage pT3

By Schelin Sonny   Madsen Mikael   Palmqvist Elisabeth   Makela Erik   Klintenberg Claes   Aus Gunnar  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 3, 2009-04 ,pp. : 186-191

Informa Healthcare

Access to resources Recommend Favorite

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up

By Oh W.K.   Manola J.   Bittmann L.   Brufsky A.   Kaplan I.D.   Smith M.R.   Kaufman D.S.   Kantoff P.W.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite